​

Vertex Pharmaceuticals Ownership | Who Owns Vertex Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Vertex Pharmaceuticals Ownership Summary


Vertex Pharmaceuticals is owned by 95.59% institutional investors, 0.21% insiders, and 4.20% retail investors. Capital world investors is the largest institutional shareholder, holding 10.28% of VRTX shares. American Funds Growth Fund of Amer A is the top mutual fund, with 5.48% of its assets in Vertex Pharmaceuticals shares.

VRTX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockVertex Pharmaceuticals95.59%0.21%4.20%
SectorHealthcare Stocks 245.07%12.10%-157.17%
IndustryBiotech Stocks 380.48%11.73%-292.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Capital world investors26.12M10.28%$12.97B
Blackrock funding, inc. /de24.11M9.49%$11.98B
Vanguard group24.11M9.43%$10.93B
Blackrock21.31M8.25%$9.99B
Capital research global investors19.49M7.67%$9.68B
Vanguard capital management16.58M6.53%$8.24B
State street11.87M4.67%$5.90B
Invesco8.04M3.17%$4.00B
Jpmorgan chase6.52M2.56%$3.26B
Geode capital management6.02M2.37%$2.98B

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Tri locum partners lp201.79K12.33%$100.24M
Kynam capital management, lp330.00K11.93%$154.68M
Provident investment management140.73K6.79%$69.90M
Bellevue group578.63K6.05%$287.42M
Andrew hill investment advisors13.23K4.88%$6.57M
Motley fool wealth management636.004.80%$316.10K
Bridger management18.78K3.96%$7.35M
Artia global partners lp55.10K3.42%$21.58M
Sivik global healthcare10.00K3.39%$4.46M
Mcrae capital management33.19K3.24%$16.49M

Top Buyers

HolderShares% AssetsChange
Norges bank2.97M0.15%2.97M
Franklin resources3.35M0.36%2.80M
Invesco8.04M0.32%2.71M
Sixth street partners management company2.04M0.13%2.04M
Capital world investors26.12M1.53%746.89K

Top Sellers

HolderShares% AssetsChange
Parnassus investments---1.65M
Capital research global investors19.49M1.35%-1.64M
Alliancebernstein3.02M0.45%-891.47K
Winslow capital management---887.64K
Artisan partners limited partnership---650.26K

New Positions

HolderShares% AssetsChangeValue
Norges bank2.97M0.15%2.97M$1.48B
Sixth street partners management company2.04M0.13%2.04M$1.01B
Axa investment managers163.68K0.17%163.68K$64.10M
Harvest portfolios group148.19K1.04%148.19K$73.61M
Freestone grove partners lp110.28K0.32%110.28K$43.19M

Sold Out

HolderChange
Strategic advocates-1.00
Mcclarren financial advisors-1.00
Mine & arao wealth creation & management, llc.-1.00
Ruedi wealth management-1.00
Cgc financial services-1.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20261,7931.88%242,903,7273.31%951.12%8845.36%6162.16%
Mar 31, 20261,587-7.84%210,840,715-10.55%820.97%765-12.97%538-6.43%
Dec 31, 2025806-48.63%44,328,589-80.90%170.21%410-40.58%269-56.19%
Sep 30, 2025865-46.24%59,581,660-75.23%230.26%362-50.82%356-41.54%
Jun 30, 20251,575-5.06%240,147,0121.70%931.11%716-14.86%5994.90%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
American Funds Growth Fund of Amer A13.93M5.48%950.21K
Capital Group Growth Fnd of Amer Comp12.54M4.94%-1.39M
American Funds Growth Fd of Amer A12.54M4.94%-1.39M
Vanguard MStar Total Stk Mkt Idx Invest8.08M3.19%23.19K
Vanguard US Total Market Shares ETF8.18M3.19%16.09K
Vanguard Morn Total Stk Mkt Idx Investor8.06M3.18%-26.52K
Vanguard Total Stock Mkt Idx Inv8.06M3.18%-26.52K
Vanguard Institutional 500 Index Trust7.30M2.84%51.91K
Vanguard 500 Index Investor6.66M2.63%70.31K
Capital Group Investment Co of Amer Comp6.27M2.47%-

Recent Insider Transactions


DateNameRoleActivityValue
Jul 02, 2026Tatsis Ourania EVP, Chief Reg. & Quality Off.Sell$787.49K
Jul 02, 2026McKechnie Duncan EVP, Chief Commercial OfficerSell$799.78K
Jul 01, 2026Liu Joy EVP and Chief Legal OfficerSell$416.24K
Jun 26, 2026Bozic Carmen EVP and CMOSell$287.57K
Jun 18, 2026Bozic Carmen EVP and CMOSell$471.41K

Insider Transactions Trends


DateBuySell
2026 Q3-3
2026 Q2-11
2026 Q1-56
2025 Q4-23
2025 Q341

VRTX Ownership FAQ


Who Owns Vertex Pharmaceuticals?

Vertex Pharmaceuticals shareholders are primarily institutional investors at 95.59%, followed by 0.21% insiders and 4.20% retail investors. The average institutional ownership in Vertex Pharmaceuticals's industry, Biotech Stocks , is 380.48%, which Vertex Pharmaceuticals falls below.

Who owns the most shares of Vertex Pharmaceuticals?

Vertex Pharmaceuticals’s largest shareholders are Capital world investors (26.12M shares, 10.28%), Blackrock funding, inc. /de (24.11M shares, 9.49%), and Vanguard group (24.11M shares, 9.43%). Together, they hold 29.20% of Vertex Pharmaceuticals’s total shares outstanding.

Does Blackrock own Vertex Pharmaceuticals?

Yes, BlackRock owns 8.25% of Vertex Pharmaceuticals, totaling 21.31M shares as of Jun 2024. This represents 0.23% of BlackRock's total assets, with a market value of 9.99B$. In the last quarter, BlackRock decreased its holdings by -648K shares, a -2.95% change.

Who is Vertex Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Tri locum partners lp is Vertex Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 12.33% of its assets in 201.79K Vertex Pharmaceuticals shares, valued at 100.24M$.

Who is the top mutual fund holder of Vertex Pharmaceuticals shares?

American Funds Growth Fund of Amer A is the top mutual fund holder of Vertex Pharmaceuticals shares, with 5.48% of its total shares outstanding invested in 13.93M Vertex Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools